药物片中的多态变化的空间和时间可视化
Julia Gasol-Cardona1,2, Martin R Ward1,2, Olof Gutowski3
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, United Kingdom.
Angewandte Chemie (International ed. in English)
|November 15, 2024
概括
射线衍射计算机断层扫描 (XRD-CT) 不破坏性地分析药物片,揭示压缩诱导的物质变化和糖类标记物随时间的现场水解反应.
科学领域:
- 材料科学 材料科学 材料科学
- 制药科学 制药科学
- 分析化学 分析化学
背景情况:
- 非破坏性分析对于药物药片的表征至关重要.
- 了解压缩下的材料转化对于制造至关重要.
- 射线衍射计算机断层扫描 (XRD-CT) 提供具有空间分辨率的分子层次洞察力.
研究的目的:
- 应用XRD-CT用于在不同压缩压力下分析药品片.
- 为了研究压力诱导的转化,在药片内的糖类物质标记物.
- 研究药片成分的时间变化,包括水解.
主要方法:
- 应用X射线衍射计算机断层扫描 (XRD-CT) 在药物片上.
- 使用压力敏感的甘化物标记物来追踪压缩效应.
- 在一个月后进行后续分析,观察现场反应.
- 使用电子衍射来阐明水解产品的结构.
主要成果:
- 在没有破坏的情况下,XRD-CT成功地揭示了药片内的物质变化.
- 压力诱导的糖化物转化被精确地定位在平板结构内.
- 在压缩后一个月观察到glycolide的in situ水解反应.
- 用电子衍射测定了甘化物水解产品的结构.
结论:
- XRD-CT是一种强大的工具,用于制药片制造工艺的非破坏性分析.
- 该研究表明,它能够随着时间的推移跟踪药片内的动态物质变化和反应.
- 了解这些转变是优化平板电脑质量和稳定性的关键.
相关概念视频
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
287
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
287
Factors Influencing Drug Absorption: Pharmaceutical Parameters
121
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
121
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K
Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
64
When drugs are administered extravascularly, a comprehensive evaluation through noncompartmental analysis becomes imperative. This analytical approach considers various parameters that play a crucial role in understanding the pharmacokinetics of these drugs.
One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area...
One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area...
64
Drug Administration and Therapy Phases: Overview
409
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
409
Pharmacokinetic Models: Overview
592
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
592


